COVID prevention study for kidney patients pulled before it started
NCT ID NCT05110651
First seen May 19, 2026 · Last updated May 20, 2026 · Updated 1 time
Summary
This study aimed to see if hydroxychloroquine could prevent COVID-19 hospitalizations in adults on dialysis for kidney failure. It was planned as a randomized trial but was withdrawn before any participants were enrolled. No results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Herlev Hospital
Herlev, Herlev, 2730, Denmark
-
North Zealand Hospital
Hillerød, Hillerød, 3400, Denmark
-
Rigshospitalet
Copenhagen, Copenhagen, 2100, Denmark
Conditions
Explore the condition pages connected to this study.